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Abstract Clostridium botulinum type B neurotoxin is a highly 
specific zinc-endopeptidase which cleaves vesicle-associated 
membrane protein (VAMP/synaptobrevin), a critical component 
of the vesicle docking/fusion mechanism. In this study, substrate 
residues flanking the N-terminal side of the cleavage site are 
shown to play a key role in enzyme substrate recognition. Two 
aspartate residues in this region are identified as critical 
determinants of the neurotoxin's pecificity. These findings are 
discussed in relation to the mechanism by which botulinum type B 
neurotoxin cleaves its substrate. 
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1. Introduction 
The clostridial neurotoxins include tetanus toxin and the 
seven antigenically different botulinum neurotoxins, all of 
which exert their action by blocking the calcium-mediated 
release of neurotransmitters [1,2]. The botulinum neurotoxins 
act on the peripheral nervous system where they inhibit the 
release of acetylcholine at the neuromuscular junction, an ac- 
tion which results in widespread paralysis and ultimately the 
syndrome botulism. In their activated forms, the clostridial 
neurotoxins consist of two subunits: a heavy chain (100 
kDa) and a light chain (50 kDa), linked by a disulphide 
bridge. Present data suggest that the heavy chain primarily 
mediates toxin binding and internalisation while the light 
chain exerts its intracellular action. All of the botulinum neu- 
rotoxins have been shown to mediate this intracellular action 
via highly specific zinc-endopeptidase activities contained 
within the light subunit of  each toxin [3]. Collectively, the 
clostridial neurotoxins are known to act on various isoforms 
of just three different proteins which form part of a putative 
vesicle docking/fusion mechanism [4]. Botulinum types B, D, 
F and G cleave vesicle-associated membrane protein (VAMP 
or synaptobrevin), at different sites [5-9]. Botulinum toxins 
types A and E cleave the protein SNAP-25 at distinct sites 
close to the C-terminus [6,10,11] and botulinum type C1 toxin 
cleaves both syntaxin and SNAP-25. Tetanus toxin acts to 
cleave VAMP/synaptobrevin at an identical site to that of 
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botulinum type B toxin [5]. The clostridial neurotoxins thus 
represent some of the most specific zinc-proteases so far char- 
acterised. 
The mechanism of enzyme substrate recognition is presently 
unclear. Studies using both synthetic peptides and recombi- 
nant fragments derived from the target proteins of the toxins 
have shown that only relatively large peptide fragments (>30 
residues) are substrates for the toxin zinc-endopeptidases 
[12,13]. In the case of botulinum neurotoxin type B (BoNT/ 
B) only VAMP peptide substrates of >30 residues were 
cleaved by the toxin [12]. Even larger substrates (>50 resi- 
dues) are required by tetanus toxin and botulinum type A 
neurotoxin. Surprisingly, in a study of the peptide substrate 
specificity of BoNT/B only one VAMP residue at the cleavage 
site (Phe77) was found to be critical to the endopeptidase 
activity of the toxin [14]. These data suggest hat determinants 
other than the cleavage site sequence are required to account 
for the neurotoxin's highly specific proteolytic activity. In the 
present study, peptide substrates were used to determine the 
role of residues flanking the cleavage site of BoNT/B. Nega- 
tively charged substrate residues on the N-terminal side of the 
cleavage site are shown to be critical to the endopeptidase 
activity of BoNT/B. 
2. Materials and methods 
2.1. Purification of botulinum type B neurotoxin 
Clostridium botulinum type B neurotoxin obtained from the Okra 
strain was purified by a modification [15] of the process described for 
botulinum type F neurotoxin [16]. Purified BoNT/B was dialysed 
against 0.05 M HEPES buffer pH 7.4 containing 0.15 M NaCI and 
stored at -80°C. Reduced and alkylated BoNT/B was prepared by 
the following method. BoNT/B (3 mg m1-1) was incubated in 0.05 M 
HEPES pH 7.4 buffer containing 0.15 M NaCI and 10 mM dithio- 
threitol for 30 min at 22°C. Iodoacetamide was added to a final con- 
centration of 50 mM and the mixture incubated for 1 h at 4°C. The 
alkylated toxin was then dialysed against 0.05 M HEPES pH 7.4 
buffer containing 0.15 M NaC1 and stored at -80°C. 
2.2. Synthesis of peptides 
Peptides were synthesised on 4-(2',4'-dimethyl-Fmoc-aminomethyl)- 
phenoxy resin (Novabiochem) with an automated, solid-phase peptide 
synthesiser (model 431A, Applied Biosystems Inc, Foster City, CA) 
using Perkin-Elmer FastMoc chemistry. Peptides were purified by 
reverse-phase high pressure liquid chromatography on C8 columns 
(2.2 × 25 cm, Vydac), and characterised asdescribed previously [12]. 
Peptides containing an intramolecular disulphide bridge were pre- 
pared as follows. Peptide (2.5 rag) was dissolved in water to a con- 
centration of 0.1 mg ml 1 and the pH adjusted to 7.0 with 1 M 
NH4OH. Potassium ferricyanide (2 mg ml 1) was then added drop- 
wise until a pale yellow colour was observed and the reaction stirred 
for 1 h at 22°C. The resulting oxidised peptide was then purified and 
characterised by FAB mass spectrometry asdescribed [12]. The num- 
ber of free thiol groups was determined by reaction with 3 mM dithio- 
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Table 1 
Influence of charged residues on the cleavage of VAMP peptides by BoNT/B 
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VAMP peptide sequence Cleavage rate (nmole s -1) % Control 
(a) Influence of substitutions to negatively charged residues (X=7SETSAAKLKRKYWWKNLK 94) 
60 LSELDDRADALQAGASQ ~ F 77 -X 
LSS_LDDRADALQAGASQF-X 
LSLSSLSDRADALQAGASQF-X 
LSLSSLSSRADALQAGASQF-X 
LSLSELSSRADALQAGASQF-X 
LSRADALQAGASQF-X 
LSLSELDDRPDALQAGASQF-X 
24.5 + 1.5 100% 
27.2_+0.7 111% 
9.8 + 1.5 40% 
0.8 + 0.05 3.3% 
0.9 + 0.2 3.7% 
<0.5 <3% 
17.4 _+ 2.5 72% 
(b) Influence of substitutions to positively charged residues (X= 6°LSELDDRADALQAGAS75) 
X_76Q J. FETSAAKLKRKYWWKNLK a4 
X-QFETSAAKLKRKYWWSNLS 
X-QFETSAAKLSSKYWWKNLK 
X-QFETSAASLSRKYWWKNLK 
X-QFETSAAKL_SYWWKNLK 
27.3 + 2.5 100% 
24.8 + 2.1 91% 
9.0+0.8 33% 
7.6 _+ 0.5 27.6% 
5.5 _+ 0.4 20.2% 
Substituted residues are shown underlined. The cleavage site for BoNTIB is indicated by the arrow. A putative motif region (residues 62 70) is 
shown as bold characters in the first sequence. 
nitrobenzoate in 0.1 M sodium phosphate buffer pH 7.3 containing 
0.1 mM EDTA. Molar extinction coefficients of 14 150 M -1 cm -1 
(412 nm) and 12315 M -1 cm -1 (280 nm) were used for the nitrothio- 
benzoate ion and the peptides respectively. 
2.3. Cleavage of VAMP peptides by BoNTIB 
Peptides (0.31 mM) in 50 mM HEPES buffer pH 7.2 containing 10 
mM ZnC12 and 10 mM 2-mercaptoethanol were incubated at 37°C for 
20 min. BoNT/B was diluted with 50 mM HEPES buffer pH 7.2 
containing 10 mM dithiothreitol and 20 mM ZnC12 and incubated 
at 37°C for 20 min. In the case of the cleavage of disulphide-loop 
peptides, 2-mercaptoethanol and dithiothreitol were omitted from the 
incubation mixtures. Reactions were initiated by addition of 10 ml of 
toxin solution to the 250 ml peptide mixture and then incubated at 
37°C for 30 min. Proteolysis were stopped by the addition of 0.5 ml of 
0.5% (by vol) trifluoroacetic acid. Final concentrations of BoNT/B 
were between 3 and 100 nM and were chosen so that less than 15% 
of the total peptide was cleaved uring the reaction time. The extent 
of peptide cleavage was estimated from HPLC analysis of reaction 
mixtures on C8 columns (4.6x45 mm, Ultrasphere, Beckman) as 
described [12]. Initial rates of peptide cleavage were estimated from 
the integral analysis of the two fragment peak areas as well as that of 
the parent peak. Concentrations of peptide solutions were estimated 
from absorbance of the tryptophan and tyrosine residues at 280 nm. 
All determinations of cleavage rates were performed in triplicate. 
3. Results 
The endopeptidase activity of BoNT/B was studied with 
either VAMP(60-94) or VAMP(62-91) synthetic peptides de- 
rived from the sequence of human VAMP isoform-2. These 
peptides are cleaved by BoNT/B at the Gln76-Phe77 bond, 
consistent with in vivo observations and at the same rate as 
larger fragments of VAMP, making them convenient model 
substrates with which to study the endopeptidase activity of 
BoNT/B [12,14]. 
3.1. Effect of substitution of charged substrate residues on the 
cleavage rate by BoNTIB 
The distribution of  charged residues within the VAMP(60-  
94) peptide substrate is such that the N-terminal region con- 
sists largely of negatively charged residues while the C-ter- 
minal region is predominantly positively charged. Table 1 
illustrates the effect of neutralisation of these charged residues 
on the cleavage rate of BoNT/B. Substitution of Glu62 with a 
serine residue, a neutral but hydrophilic residue, had no effect 
on the cleavage rate. Similar changes to either Asp64 or 
Asp65 reduced the cleavage rate to approximately 30-40% 
of the control value. Substitution or removal of both the 
Asp64 and Asp65 virtually abolished cleavage of the peptide 
by BoNT/B. Since Asp64,65 lie in a peptide sequence pre- 
dicted to adopt an a-helical structure [17], the effect of dis- 
rupting such secondary structure was investigated by inserting 
a proline residues in this region. Substitution of Ala67 with a 
proline residue did not significantly reduce the cleavage rate 
by BoNT/B (Table la). 
Analogous substitutions to the positively charged residues 
to the C-terminal side of the cleavage site were also studied. 
Replacement of both Lys91 and Lys94 with serine did not 
significantly affect the cleavage rate by BoNT/B. Substitution 
of various combinations of the cluster of the positively 
charged residues between Lys83 and Lys87, however, reduced 
the cleavage rate by BoNT/B to 20-30% of control values 
(Table lb). 
3.2. Effect of deletion of substrate residues on the cleavage rate 
by BoNTIB 
The above data suggests that residues N-terminal to the 
cleavage site of BoNT/B play a key role in enzyme substrate 
recognition. To assess the importance of relative position of 
these residues with respect o the cleavage site the effect of the 
addition and deletion of amino acid residues was studied. 
Deletion of either Ala69 or Ala72 greatly reduced the cleavage 
rate by BoNT/B (Table 2a). In control experiments in which 
Ala69 was substituted for a cysteine residue the cleavage rate 
was not significantly reduced compared to control values il- 
lustrating that the properties of the amino acid side chain are 
not critical to substrate recognition (result not shown). Addi- 
tion of an alanine residue at position 72 was found to com- 
pletely abolish peptide cleavage by BoNT/B (Table 2a). Anal- 
ogous experiments were performed to investigate the role of 
deleting residues in the peptide sequence flanking the C-ter- 
minal side of the cleavage site. In contrast o the above, dele- 
tion of either Ala82 or Leu85 were both found to result in a 
slight increase in the peptide cleavage rate by BoNT/B 
(Table 2b). 
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Table 2 
Influence of residue deletions/additions  the cleavage of VAMP peptides by BoNT/B 
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VAMP peptide sequence Cleavage rate (nmole s -1) % Control 
(a) Deletions~additions to the N-terminal region (X=ZSETSAAKLKRKYWWKNLK a4) 
62ELDDRADALQAGASQ ~ F77-X 23.4 + 1.5 
ELDDRAD-LQAGASQF-X 2.9 + 0.3 
ELDDRADALQ-GASQF-X <0.5 
ELDDRADALQAAGASQF-X <0.5 
(b) Deletions to the C-terminal region (X= 6ZELDDRADALQAGAS75) 
X-76Q ~ FETSAAKLKRKYWWKNLK 94 13.4 + 1.6 
X-QFETSA-KLKRKYWWKNLK 15.5 + 1.9 
X-QFETSAAK-KRKYWWKNLK 17.2 + 2.1 
100% 
12.3% 
<2% 
<2% 
100% 
116% 
128% 
Amino acid deletions are indicated by a hyphen; additions are shown underlined. The cleavage site for BoNT/B is indicated by the arrow. 
Concentrations of BoNT/B were 10 nM in a and 3.3 nM in b. 
3.3. Cleavage of  disulphide-loop VAMP peptides by BoNTIB 
To investigate the influence of substrate conformation on 
the cleavage rate by BoNT/B, VAMP(60-91) peptides con- 
taining an intra-chain disulphide bridge were produced (Table 
3). Disulphide bridges were introduced into peptides by oxida- 
tion of dilute solutions of peptide with potassium ferricyanide. 
Mass spectrometry of the oxidised peptides howed the puri- 
fied products to be 2 mass units smaller than the correspond- 
ing reduced peptide illustrating the successful formation of 
intra-chain disulphide bridges. In addition, no free thiol 
groups were detectable in these peptides. To avoid the use 
of thiol reagents in the reaction mixtures, BoNT/B which 
has been reduced and alkylated was used for this part of 
the study. BoNT/B treated in this way was found to retain 
approximately 70% of its original activity. A VAMP peptide 
containing a cysteine bridge between positions 69 and 84 was 
poorly cleaved by BoNT/B while no detectable cleavage was 
observed with a peptide containing a cysteine bridge between 
positions 67 and 84. In control experiments, both peptides 
were cleaved rapidly prior to oxidation. In the case of 
VAMP (Cys69,84) treatment of the oxidised peptide with 
dithiothreitol recovered more than 60% of the cleavage rate 
of the non-oxidised control. 
4. Discussion 
The clostridial neurotoxins are among the most specific 
proteases characterised. VAMP/synaptobrevin appears to be 
the only protein cleaved by BoNT/B which, like tetanus toxin, 
cleaves the protein at a single site between Gln76 and Phe77 
[5]. The mechanism by which BoNT/B recognises its target 
protein is unclear. Previous studies have shown that the pri- 
mary structure of the peptide in the vicinity of the cleavage 
site is insufficient to account for the specificity of the endo- 
peptidase since modified sequences are still cleaved by BoNT/ 
B [14]. One possibility is that BoNT/B requires a unique pep- 
tide conformation for cleavage. Another possible mechanism 
is that, in addition to the site of cleavage, there are one or 
more sub-sites or recognition sites where the substrate binds 
to the neurotoxin. Recently, it has been suggested that a nine 
residue motif (residues 62 70; see Table 1), of which there are 
multiple copies in VAMP, syntaxin and SNAP-25 acts as a 
common recognition site for the clostridial toxins [17]. Strong 
evidence in favour of such a mechanism is the observation 
that the endopeptidase activity of one neurotoxin serotype 
can be inhibited by the presence another toxin serotype which 
suggests a common recognition element [17]. Data presented 
in the present study support he hypothesis of a sub-site for 
substrate binding in the case of BoNT/B. Neutralisation of the 
negatively charged residues, Asp64 and 65, which lie within 
the putative motif region (Table 1), virtually abolished sub- 
strate cleavage by BoNT/B. These data may indicate a role for 
these charged residues in binding at a sub-site. If Asp64 and 
65 do play a direct role in substrate binding then the distance 
between the motif region and the cleavage site should be crit- 
ical. Consistent with this is the greatly reduced rates of cleav- 
age observed with substrates in which either a residue deletion 
or addition had been made at Ala 69 or 72. In contrast, 
analogous deletions made on the C-terminal side of the cleav- 
age site had no inhibitory effect on the cleavage rate. Collec- 
tively these data suggest a key role for substrate residues N- 
terminal to the cleavage site as determinants of the specificity 
of BoNT/B. This region of VAMP has also been identified as 
a conserved signal sequence which plays a role in the regula- 
tion of VAMP transport to synaptic vesicles [18,19]. 
Insertion of a proline residue within the motif region on 
VAMP peptide substrates only slightly reduced the rate of 
substrate cleavage. This observation is inconsistent with pre- 
Table 3 
Cleavage of disulphide-loop peptides by BoNT/B 
VAMP peptide Cleavage rate (nmole s 1) % Control 
VAMP(Cys69,84) reduced 23.4 + 0.9 100% 
VAMP(Cys69,84) oxidised 3.2 _+ 0.3 4.4% 
VAMP(Cys67,84) reduced 23.4 + 0.9 100% 
VAMP(Cys67,84) oxidised <0.5 <2% 
Cleavage reactions were performed using 100 nM alkylated BoNT/B and 0.3 mM peptide. Peptides were oxidised by treatment with potassium 
ferricyanide as described in Section 2. Peptide sequences were:VAMP(Cys69,84)= 62LSELDDRADCLQAGASQFETSAAKCKRKYWWK91 
VAMP(Cys67,84) =62 LSELDDRCDALQAGASQFETSAAKCKRKYWWK 91 .
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dictions of an a-helical structure for this region [17] and also 
suggests that any binding to the toxin within this region does 
not evoke the formation of such secondary structure. 
While a model in which BoNT/B recognises its substrate via 
cleavage site and motif (sub-site) sequences could explain the 
unique specificity of the neurotoxin, this model is too simplis- 
tic to explain the available data. Previous studies have shown 
that a VAMP(55-82) peptide which contains both the motif 
and cleavage site is poorly cleaved by BoNT/B [12]. This ob- 
servation clearly suggests that substrate residues flanking the 
C-terminus of the cleavage site also play some role in sub- 
strate recognition. The possibility that this region contains a 
second sub-site for substrate binding seems unlikely since ami- 
no acid deletions in this region had little effect on the rate of 
proteolysis. Neutralisation of the positively charged residues 
in this region did reduce the cleavage rate by BoNT/B, but to 
a much lesser extent than that observed with the negatively 
charged residues in the motif region. A more likely explana- 
tion is that the residues on the C-terminal side of the cleavage 
site are required to provide a specific substrate conformation 
which is essential for cleavage by BoNT/B. Constraining 
VAMP peptides by the introduction of disulphide bridges 
greatly reduced the rate proteolysis by BoNT/B which sug- 
gests that peptide conformation is an important factor. 
Further studies are clearly required to understand the factors 
determining the specificity of BoNT/B. 
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